Insulin Glulisine
2 NDCs across 1 manufacturer|0 Generic,2 Brand
Insulin Glulisine is used to treat type 1 diabetes mellitus, type 2 diabetes mellitus and hyperglycemia, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
In 2024, Medicare Part D spent $3 million on Insulin Glulisine across 10,000 claims for 3,190 beneficiaries.
Insulin Glulisine is available as 2 NDCs from 1 manufacturer (0 generic, 2 brand), with NADAC prices from $8.16 to $10.51 per ML — a 29% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
2
0G / 2B
Manufacturers
1
competing in market
Price Spread
$8.16 – $10.51
per ML
7d Activity
avg +0.0% WoW · of 2 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
1 manufacturer producing INSULIN GLULISINE
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
APIDRA SOLOSTAR 100 UNIT/ML | $10.5079 per ML | +0.01% |
APIDRA 100 UNIT/ML VIAL | $8.1606 per ML | 0.00% |
Frequently Asked Questions
What is Insulin Glulisine used to treat?
Insulin Glulisine is used to treat type 1 diabetes mellitus, type 2 diabetes mellitus and hyperglycemia, per the National Library of Medicine's MED-RT classification.
How much does Medicare spend on Insulin Glulisine?
In 2024, Medicare Part D spent $3 million on Insulin Glulisine across 10,000 claims for 3,190 beneficiaries.
How many Insulin Glulisine products are on the market?
The Insulin Glulisine drug market contains 2 NDCs from 1 manufacturer — 0 generic and 2 brand products.
What is the price range for Insulin Glulisine?
NADAC reference prices for Insulin Glulisine range from $8.1606 to $10.5079 per ML — a 29% difference between cheapest and most expensive.
Which manufacturers make Insulin Glulisine?
1 manufacturer lists Insulin Glulisine in NADAC. Ranked by number of NDCs, the largest are Sanofi-Aventis U.S. LLC (2).
How has the price of Insulin Glulisine changed recently?
Over the past 7 days, 1 Insulin Glulisine NDC rose and 0 fell, with a market-wide average change of +0.0%.